Tempest Therapeutics (TPST) Cash & Current Investments (2011 - 2026)
Tempest Therapeutics (TPST) reported Cash & Current Investments of $800,000 for Q2 2026, down 94.4% from $14.3 million a year earlier.
Powered by 
Analysis
Tempest Therapeutics (TPST) Cash & Current Investments (2011 - 2026) Analysis & Trends
At the end of FY2025, Tempest Therapeutics posted Cash & Current Investments of $7.71 million, down 74.5% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of -16.4% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $30.27 million in FY2024 (-22.8%), $39.23 million in FY2023 (+25.6%), $31.23 million in FY2022 (-39.7%) and $51.83 million in FY2021 (+175.4%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments in data going back to Q4 2011.
- Year over year, Cash & Current Investments gained in 1 of the last seven quarters, with an average decline of 35.2%.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 217.3%); the low point was Q2 2026 (a decline of 94.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Tempest Therapeutics | 5.91 Mn | -11.91 Mn | - | 800,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 800,000.00 |
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | 7.71 Mn |
| Sep 30, 2025 | 7.51 Mn |
| Jun 30, 2025 | 14.30 Mn |
| Mar 31, 2025 | 21.51 Mn |
| Dec 31, 2024 | 30.27 Mn |
| Sep 30, 2024 | 22.12 Mn |
| Jun 30, 2024 | 31.12 Mn |
| Mar 31, 2024 | 32.33 Mn |
| Dec 31, 2023 | 39.23 Mn |
| Sep 30, 2023 | 11.12 Mn |
| Jun 30, 2023 | 17.60 Mn |
| Mar 31, 2023 | 22.93 Mn |
| Dec 31, 2022 | 31.23 Mn |
| Sep 30, 2022 | 42.79 Mn |
| Jun 30, 2022 | 51.62 Mn |
| Mar 31, 2022 | 45.75 Mn |
| Dec 31, 2021 | 51.83 Mn |
| Sep 30, 2021 | 59.72 Mn |
API Access
Tempest Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();